<DOC>
	<DOCNO>NCT00777075</DOCNO>
	<brief_summary>The purpose study determine whether treatment L-arginine lead improvement erectile dysfunction patient erectile dysfunction .</brief_summary>
	<brief_title>L-Arginine Erectile Dysfunction</brief_title>
	<detailed_description>Erectile dysfunction ( ED ) common medical disorder often affect age male . Nitric oxide ( NO ) physiological signal essential penile erection . NO synthase ( NOS ) catalyze production NO L-arginine . ADMA , competitive inhibitor NO synthase increase age many disorder reduce NO erectile tissue commonly associate ED . Although new pharmacological strategy identify medical treatment ED , patient often seek alternative therapy cost side effect reason . The aim present study determine efficacy orally administer L-arginine ED cause establish organic disease .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>Patients age 20 65 year , ED least 6 month duration write consent . Each patient inform study detail write oral form begin drug administration . The hormonal status include dehydroepiandrosterone sulfate ( DHEAS ) , Prolactin Testosteron patient within normal range . Patients primary erectile dysfunction , congenital anomaly , Diabetes mellitus , severe hepaticand renal insufficiency , severe cardiovascular disease , cerebrovascular accident , uncontrolled hypertension , endocrine disease , psychiatric disorder , evidence dementia exclude . Patients exclude pelvic fracture prostatectomy undergone reconstructive prosthetic surgery penis . Increased level serum potassium , know hypersensitivity study medication ingredient drug . Administration PDE5Inhibitors ( sildenafil , tadalafil , vardenafil apomorphine ) within four week prior administration larginine placebo lead exclusion .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>nitrate</keyword>
	<keyword>nitric oxide</keyword>
	<keyword>asymmetric dimethylarginine</keyword>
	<keyword>blood pressure</keyword>
	<keyword>NOS</keyword>
	<keyword>IIEF</keyword>
</DOC>